LABELS · bb82db71-b087-4274-bd9c-cb388d7dbaeb
IC-Green
Open original source → · Download preserved record
Preserved label snapshot, not confirmation of a current approved indication. Approval/withdrawal status must be checked for the exact disease, setting and regimen.
- Label effective date
- 2026-01-30
- Captured
- 2026-09-09T23:37:58.719708+00:00
- Current indication reconciliation
- Not reconciled
Indications and usage: exact source text
- 1 INDICATIONS AND USAGE • Fluorescence imaging of vessels (micro- and macro-vasculature), blood flow and tissue perfusion before, during and after vascular, gastrointestinal, organ transplant, plastic, micro- and reconstructive surgeries, including general minimally invasive surgical procedures, in adults and pediatric patients aged 1 month and older ( 1.1 ) • Fluorescence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older ( 1.2 ) • Fluorescence imaging of lymph nodes and lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer ( 1.3 ) • Ophthalmic angiography in adults and pediatric patients ( 1.4 ) 1.1 Visualization of Vessels, Blood Flow and Tissue Perfusion IC-GREEN is indicated for fluorescence imaging of vessels (micro- and macro- vasculature), blood flow and tissue perfusion before, during and after vascular, gastrointestinal, organ transplant, plastic, micro- and reconstructive surgeries, including general minimally invasive surgical procedures in adults and pediatric patients aged 1 month and older. 1.2 Visualization of Extrahepatic Biliary Ducts IC-GREEN is indicated for fluorescence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older . 1.3 Lymphatic Mapping of Cervical and Uterine Cancer IC-GREEN is indicated for fluorescence imaging of lymph nodes and delineation of lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer for which this procedure is a component of intraoperative management . 1.4 Ophthalmic Angiography IC-GREEN is indicated for use in ophthalmic angiography in adults and pediatric patients.
Full extracted label fields
- application numbers
- NDA011525
- boxed warning exact
- brand names
- IC-Green
- current indication status
- not_reconciled
- dailymed set url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ccd92843-1f0a-4ece-9978-4b300d158886
- generic names
- INDOCYANINE GREEN
- id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- indications and usage exact
- 1 INDICATIONS AND USAGE • Fluorescence imaging of vessels (micro- and macro-vasculature), blood flow and tissue perfusion before, during and after vascular, gastrointestinal, organ transplant, plastic, micro- and reconstructive surgeries, including general minimally invasive surgical procedures, in adults and pediatric patients aged 1 month and older ( 1.1 ) • Fluorescence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older ( 1.2 ) • Fluorescence imaging of lymph nodes and lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer ( 1.3 ) • Ophthalmic angiography in adults and pediatric patients ( 1.4 ) 1.1 Visualization of Vessels, Blood Flow and Tissue Perfusion IC-GREEN is indicated for fluorescence imaging of vessels (micro- and macro- vasculature), blood flow and tissue perfusion before, during and after vascular, gastrointestinal, organ transplant, plastic, micro- and reconstructive surgeries, including general minimally invasive surgical procedures in adults and pediatric patients aged 1 month and older. 1.2 Visualization of Extrahepatic Biliary Ducts IC-GREEN is indicated for fluorescence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older . 1.3 Lymphatic Mapping of Cervical and Uterine Cancer IC-GREEN is indicated for fluorescence imaging of lymph nodes and delineation of lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer for which this procedure is a component of intraoperative management . 1.4 Ophthalmic Angiography IC-GREEN is indicated for use in ophthalmic angiography in adults and pediatric patients.
- indications and usage tables exact
- is original packager
- true
- manufacturer names
- Renew Pharmaceuticals Limited
- matched search terms
- cancer
- package ndcs
- 70100-825-02
- 70100-725-01
- 0409-4887-17
- 70100-810-02
- 70100-710-01
- product ndcs
- 70100-810
- 70100-825
- product types
- HUMAN PRESCRIPTION DRUG
- recent major changes exact
- Indications and Usage, For determining Cardiac Output, Hepatic Function, and Liver Blood Flow (1.1) Removed 12/2024 Indications and Usage ( 1.1 , 1.2 , 1.3 ) 12/2024 Dosage and Administration, Indicator-Dilution Studies and Hepatic Function Studies (2.1, 2.2) Removed 12/2024 Dosage and Administration ( 2.1 , 2.2 , 2.3 , 2.5 ) 12/2024 Dosage and Administration ( 2.5 ) 01/2026
- record type
- complete_spl_indications_section_candidate
- routes
- rxcuis
- source batch
- file
- /private/tmp/cancer-full-research/indications/raw/labels-00600.json
- meta
- disclaimer
- Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
- last updated
- 2026-09-09
- results
- limit
- 100
- skip
- 600
- total
- 830
- sha256
- a9df7a5786dc51557d38f2a0881b5b5e9ae02ae396a6798e39ac96f586bcc5e6
- source url
- https://api.fda.gov/drug/label.json?search=id%3A%22bb82db71-b087-4274-bd9c-cb388d7dbaeb%22
- spl effective date
- 2026-01-30
- spl effective time
- 20260130
- spl set id
- ccd92843-1f0a-4ece-9978-4b300d158886
- spl version
- 4
- substance names
- uniis
- verification flags
- oncology_keyword_candidate_not_clinically_classified
- spl_text_not_verified_identical_to_latest_approved_label
- individual_indications_not_split_or_reconciled
- fda_label_posted_after_spl_effective_date_requires_version_review
Drugs@FDA application source records
- application number
- NDA011525
- payload
- all indexed label documents
- Appl No
- 011525
- Application Docs Date
- 2015-10-08 00:00:00
- Application Docs ID
- 10764
- Application Docs Title
- 0
- Application Docs Type ID
- 2
- Application Docs URL
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/011525s027lbl.pdf
- Submission No
- 27
- Submission Type
- SUPPL
- Appl No
- 011525
- Application Docs Date
- 2006-09-25 00:00:00
- Application Docs ID
- 33047
- Application Docs Title
- 0
- Application Docs Type ID
- 2
- Application Docs URL
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/011525s017lbl.pdf
- Submission No
- 17
- Submission Type
- SUPPL
- Appl No
- 011525
- Application Docs Date
- 2022-03-29 00:00:00
- Application Docs ID
- 70635
- Application Docs Title
- 0
- Application Docs Type ID
- 2
- Application Docs URL
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/011525Orig1s036lbl.pdf
- Submission No
- 36
- Submission Type
- SUPPL
- Appl No
- 011525
- Application Docs Date
- 2025-03-14 00:00:00
- Application Docs ID
- 80539
- Application Docs Title
- 0
- Application Docs Type ID
- 2
- Application Docs URL
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/011525Orig1s039lbl.pdf
- Submission No
- 39
- Submission Type
- SUPPL
- Appl No
- 011525
- Application Docs Date
- 2026-04-24 00:00:00
- Application Docs ID
- 85737
- Application Docs Title
- 0
- Application Docs Type ID
- 2
- Application Docs URL
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/011525Orig1s043lbl.pdf
- Submission No
- 43
- Submission Type
- SUPPL
- Appl No
- 011525
- Application Docs Date
- 2026-07-20 00:00:00
- Application Docs ID
- 86587
- Application Docs Title
- 0
- Application Docs Type ID
- 2
- Application Docs URL
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/011525Orig1s042lbl.pdf
- Submission No
- 42
- Submission Type
- SUPPL
- all submission records
- Appl No
- 011525
- Review Priority
- STANDARD
- Submission Class Code ID
- 3
- Submission No
- 43
- Submission Status
- AP
- Submission Status Date
- 2026-04-22 00:00:00
- Submission Type
- SUPPL
- Submissions Public Notes
- Appl No
- 011525
- Review Priority
- N/A
- Submission Class Code ID
- 4
- Submission No
- 42
- Submission Status
- AP
- Submission Status Date
- 2026-01-30 00:00:00
- Submission Type
- SUPPL
- Submissions Public Notes
- Appl No
- 011525
- Review Priority
- STANDARD
- Submission Class Code ID
- 2
- Submission No
- 39
- Submission Status
- AP
- Submission Status Date
- 2024-12-05 00:00:00
- Submission Type
- SUPPL
- Submissions Public Notes
- Appl No
- 011525
- Review Priority
- STANDARD
- Submission Class Code ID
- 3
- Submission No
- 36
- Submission Status
- AP
- Submission Status Date
- 2022-03-17 00:00:00
- Submission Type
- SUPPL
- Submissions Public Notes
- Appl No
- 011525
- Review Priority
- N/A
- Submission Class Code ID
- 4
- Submission No
- 31
- Submission Status
- TA
- Submission Status Date
- 2022-08-08 00:00:00
- Submission Type
- SUPPL
- Submissions Public Notes
- Appl No
- 011525
- Review Priority
- STANDARD
- Submission Class Code ID
- 3
- Submission No
- 27
- Submission Status
- AP
- Submission Status Date
- 2015-10-05 00:00:00
- Submission Type
- SUPPL
- Submissions Public Notes
- Appl No
- 011525
- Review Priority
- STANDARD
- Submission Class Code ID
- 3
- Submission No
- 17
- Submission Status
- AP
- Submission Status Date
- 2006-09-22 00:00:00
- Submission Type
- SUPPL
- Submissions Public Notes
- Appl No
- 011525
- Review Priority
- PRIORITY
- Submission Class Code ID
- 4
- Submission No
- 15
- Submission Status
- AP
- Submission Status Date
- 1998-03-02 00:00:00
- Submission Type
- SUPPL
- Submissions Public Notes
- Appl No
- 011525
- Review Priority
- PRIORITY
- Submission Class Code ID
- 4
- Submission No
- 14
- Submission Status
- AP
- Submission Status Date
- 1997-10-21 00:00:00
- Submission Type
- SUPPL
- Submissions Public Notes
- Appl No
- 011525
- Review Priority
- PRIORITY
- Submission Class Code ID
- 4
- Submission No
- 13
- Submission Status
- AP
- Submission Status Date
- 1995-03-30 00:00:00
- Submission Type
- SUPPL
- Submissions Public Notes
- Appl No
- 011525
- Review Priority
- PRIORITY
- Submission Class Code ID
- 4
- Submission No
- 12
- Submission Status
- AP
- Submission Status Date
- 1995-03-30 00:00:00
- Submission Type
- SUPPL
- Submissions Public Notes
- Appl No
- 011525
- Review Priority
- Submission Class Code ID
- 3
- Submission No
- 11
- Submission Status
- AP
- Submission Status Date
- 1991-06-05 00:00:00
- Submission Type
- SUPPL
- Submissions Public Notes
- application number
- NDA011525
- approval interpretation
- Application linkage and approved submission are not indication-level current approval verification
- current indication status
- not_reconciled
- drugsfda url
- https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011525
- has approved submission record
- true
- latest approved submission date
- 2026-04-22
- latest label selection rule
- max FDA ApplicationDocsDate, including all ties; posting date is not approval date and latest indexed document may be incomplete
- latest posted label documents
- Appl No
- 011525
- Application Docs Date
- 2026-07-20 00:00:00
- Application Docs ID
- 86587
- Application Docs Title
- 0
- Application Docs Type ID
- 2
- Application Docs URL
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/011525Orig1s042lbl.pdf
- Submission No
- 42
- Submission Type
- SUPPL
- official application record
- Appl No
- 011525
- Appl Public Notes
- Appl Type
- NDA
- Sponsor Name
- RENEW PHARMS
- openfda application present
- true
- products
- Active Ingredient
- INDOCYANINE GREEN
- Appl No
- 011525
- Drug Name
- IC-GREEN
- Form
- INJECTABLE;INJECTION
- Product No
- 001
- Reference Drug
- 1
- Reference Standard
- 0
- Strength
- 25MG/VIAL
- marketing status
- Prescription
- Active Ingredient
- INDOCYANINE GREEN
- Appl No
- 011525
- Drug Name
- IC-GREEN
- Form
- INJECTABLE;INJECTION
- Product No
- 002
- Reference Drug
- 0
- Reference Standard
- 0
- Strength
- 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
- marketing status
- Discontinued
- Active Ingredient
- INDOCYANINE GREEN
- Appl No
- 011525
- Drug Name
- IC-GREEN
- Form
- INJECTABLE;INJECTION
- Product No
- 003
- Reference Drug
- 0
- Reference Standard
- 1
- Strength
- 10MG/VIAL
- marketing status
- Prescription
- Active Ingredient
- INDOCYANINE GREEN
- Appl No
- 011525
- Drug Name
- IC-GREEN
- Form
- INJECTABLE;INJECTION
- Product No
- 004
- Reference Drug
- 0
- Reference Standard
- 0
- Strength
- 40MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
- marketing status
- Discontinued
Source passages and status connections
Passage 1 · unclassified context
- application numbers
- NDA011525
- brand names
- IC-Green
- classification reasons
- no_unambiguous_positive_indication_predicate
- clinical review status
- pending
- content role
- unclassified_context
- context span
- end
- 223
- end exclusive
- true
- exact text
- 1 INDICATIONS AND USAGE • Fluorescence imaging of vessels (micro- and macro-vasculature), blood flow and tissue perfusion before, during and after vascular, gastrointestinal, organ transplant, plastic, micro- and reconstruc
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 0
- current approval status
- not_reconciled
- duplicate text group
- dup-cd1e9e7057ddf9c30aff
- extraction review status
- automated_candidate_pending_source_review
- generic names
- INDOCYANINE GREEN
- id
- ind-span-666514300aa84ede4865
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- positive predicate support span
- Source null
- qualifier mentions
- regulatory links
- schema version
- 0.1.0
- source batch sha256
- a9df7a5786dc51557d38f2a0881b5b5e9ae02ae396a6798e39ac96f586bcc5e6
- source defined aliases
- source span
- end
- 23
- end exclusive
- true
- exact text
- 1 INDICATIONS AND USAGE
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 0
- source url
- https://api.fda.gov/drug/label.json?search=id%3A%22bb82db71-b087-4274-bd9c-cb388d7dbaeb%22
- spl effective date
- 2026-01-30
- spl set id
- ccd92843-1f0a-4ece-9978-4b300d158886
- spl version
- 4
- structured fields status
- not_extracted_no_values_inferred_from_mentions
- structured indication
- age
- Source null
- approval pathway
- Source null
- biomarker and test
- Source null
- disease stage
- Source null
- limitations
- Source null
- line
- Source null
- prior therapy
- Source null
- regimen
- Source null
- tumor histology
- Source null
- use intent
- unclear
Passage 2 · unclassified context
- application numbers
- NDA011525
- brand names
- IC-Green
- classification reasons
- no_unambiguous_positive_indication_predicate
- clinical review status
- pending
- content role
- unclassified_context
- context span
- end
- 560
- end exclusive
- true
- exact text
- 1 INDICATIONS AND USAGE • Fluorescence imaging of vessels (micro- and macro-vasculature), blood flow and tissue perfusion before, during and after vascular, gastrointestinal, organ transplant, plastic, micro- and reconstructive surgeries, including general minimally invasive surgical procedures, in adults and pediatric patients aged 1 month and older ( 1.1 ) • Fluorescence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older ( 1.2 ) • Fluorescence imaging of lymph nodes and lymphatic vessels during lymphatic mapp
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 0
- current approval status
- not_reconciled
- duplicate text group
- dup-3c9a31d9500e264742a6
- extraction review status
- automated_candidate_pending_source_review
- generic names
- INDOCYANINE GREEN
- id
- ind-span-80a76c5d03ae21468125
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- positive predicate support span
- Source null
- qualifier mentions
- context exact
- ncluding general minimally invasive surgical procedures, in adults and pediatric patients aged 1 month and older ( 1.1 )
- kind
- age
- polarity
- not_inferred
- span
- end
- 306
- end exclusive
- true
- exact text
- adults
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 300
- context exact
- neral minimally invasive surgical procedures, in adults and pediatric patients aged 1 month and older ( 1.1 )
- kind
- age
- polarity
- not_inferred
- span
- end
- 329
- end exclusive
- true
- exact text
- pediatric patients
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 311
- context exact
- asive surgical procedures, in adults and pediatric patients aged 1 month and older ( 1.1 )
- kind
- age
- polarity
- not_inferred
- span
- end
- 356
- end exclusive
- true
- exact text
- aged 1 month and older ( 1
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 330
- regulatory links
- schema version
- 0.1.0
- source batch sha256
- a9df7a5786dc51557d38f2a0881b5b5e9ae02ae396a6798e39ac96f586bcc5e6
- source defined aliases
- source span
- end
- 360
- end exclusive
- true
- exact text
- • Fluorescence imaging of vessels (micro- and macro-vasculature), blood flow and tissue perfusion before, during and after vascular, gastrointestinal, organ transplant, plastic, micro- and reconstructive surgeries, including general minimally invasive surgical procedures, in adults and pediatric patients aged 1 month and older ( 1.1 )
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 24
- source url
- https://api.fda.gov/drug/label.json?search=id%3A%22bb82db71-b087-4274-bd9c-cb388d7dbaeb%22
- spl effective date
- 2026-01-30
- spl set id
- ccd92843-1f0a-4ece-9978-4b300d158886
- spl version
- 4
- structured fields status
- not_extracted_no_values_inferred_from_mentions
- structured indication
- age
- Source null
- approval pathway
- Source null
- biomarker and test
- Source null
- disease stage
- Source null
- limitations
- Source null
- line
- Source null
- prior therapy
- Source null
- regimen
- Source null
- tumor histology
- Source null
- use intent
- unclear
Passage 3 · unclassified context
- application numbers
- NDA011525
- brand names
- IC-Green
- classification reasons
- no_unambiguous_positive_indication_predicate
- clinical review status
- pending
- content role
- unclassified_context
- context span
- end
- 678
- end exclusive
- true
- exact text
- rointestinal, organ transplant, plastic, micro- and reconstructive surgeries, including general minimally invasive surgical procedures, in adults and pediatric patients aged 1 month and older ( 1.1 ) • Fluorescence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older ( 1.2 ) • Fluorescence imaging of lymph nodes and lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer ( 1.3 ) • Ophthalmic angiography in adults and pediatric patients ( 1.4
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 161
- current approval status
- not_reconciled
- duplicate text group
- dup-94f3b1bc263ff14fcc14
- extraction review status
- automated_candidate_pending_source_review
- generic names
- INDOCYANINE GREEN
- id
- ind-span-e5610271f8ba42b7981d
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- positive predicate support span
- Source null
- qualifier mentions
- context exact
- • Fluorescence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older ( 1.2 )
- kind
- age
- polarity
- not_inferred
- span
- end
- 423
- end exclusive
- true
- exact text
- adults
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 417
- context exact
- escence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older ( 1.2 )
- kind
- age
- polarity
- not_inferred
- span
- end
- 446
- end exclusive
- true
- exact text
- pediatric patients
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 428
- context exact
- extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older ( 1.2 )
- kind
- age
- polarity
- not_inferred
- span
- end
- 474
- end exclusive
- true
- exact text
- aged 12 years and older ( 1
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 447
- regulatory links
- schema version
- 0.1.0
- source batch sha256
- a9df7a5786dc51557d38f2a0881b5b5e9ae02ae396a6798e39ac96f586bcc5e6
- source defined aliases
- source span
- end
- 478
- end exclusive
- true
- exact text
- • Fluorescence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older ( 1.2 )
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 361
- source url
- https://api.fda.gov/drug/label.json?search=id%3A%22bb82db71-b087-4274-bd9c-cb388d7dbaeb%22
- spl effective date
- 2026-01-30
- spl set id
- ccd92843-1f0a-4ece-9978-4b300d158886
- spl version
- 4
- structured fields status
- not_extracted_no_values_inferred_from_mentions
- structured indication
- age
- Source null
- approval pathway
- Source null
- biomarker and test
- Source null
- disease stage
- Source null
- limitations
- Source null
- line
- Source null
- prior therapy
- Source null
- regimen
- Source null
- tumor histology
- Source null
- use intent
- unclear
Passage 4 · unclassified context
- application numbers
- NDA011525
- brand names
- IC-Green
- classification reasons
- no_unambiguous_positive_indication_predicate
- clinical review status
- pending
- content role
- unclassified_context
- context span
- end
- 814
- end exclusive
- true
- exact text
- gical procedures, in adults and pediatric patients aged 1 month and older ( 1.1 ) • Fluorescence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older ( 1.2 ) • Fluorescence imaging of lymph nodes and lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer ( 1.3 ) • Ophthalmic angiography in adults and pediatric patients ( 1.4 ) 1.1 Visualization of Vessels, Blood Flow and Tissue Perfusion IC-GREEN is indicated for fluorescence imaging of vessels (micro- and m
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 279
- current approval status
- not_reconciled
- duplicate text group
- dup-9868136f114fca41326c
- extraction review status
- automated_candidate_pending_source_review
- generic names
- INDOCYANINE GREEN
- id
- ind-span-9476b70821e368d3a10e
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- positive predicate support span
- Source null
- qualifier mentions
- context exact
- mph nodes and lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer ( 1.3 )
- kind
- age
- polarity
- not_inferred
- span
- end
- 573
- end exclusive
- true
- exact text
- adults
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 567
- regulatory links
- schema version
- 0.1.0
- source batch sha256
- a9df7a5786dc51557d38f2a0881b5b5e9ae02ae396a6798e39ac96f586bcc5e6
- source defined aliases
- source span
- end
- 614
- end exclusive
- true
- exact text
- • Fluorescence imaging of lymph nodes and lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer ( 1.3 )
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 479
- source url
- https://api.fda.gov/drug/label.json?search=id%3A%22bb82db71-b087-4274-bd9c-cb388d7dbaeb%22
- spl effective date
- 2026-01-30
- spl set id
- ccd92843-1f0a-4ece-9978-4b300d158886
- spl version
- 4
- structured fields status
- not_extracted_no_values_inferred_from_mentions
- structured indication
- age
- Source null
- approval pathway
- Source null
- biomarker and test
- Source null
- disease stage
- Source null
- limitations
- Source null
- line
- Source null
- prior therapy
- Source null
- regimen
- Source null
- tumor histology
- Source null
- use intent
- unclear
Passage 5 · unclassified context
- application numbers
- NDA011525
- brand names
- IC-Green
- classification reasons
- no_unambiguous_positive_indication_predicate
- clinical review status
- pending
- content role
- unclassified_context
- context span
- end
- 880
- end exclusive
- true
- exact text
- n adults and pediatric patients aged 12 years and older ( 1.2 ) • Fluorescence imaging of lymph nodes and lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer ( 1.3 ) • Ophthalmic angiography in adults and pediatric patients ( 1.4 ) 1.1 Visualization of Vessels, Blood Flow and Tissue Perfusion IC-GREEN is indicated for fluorescence imaging of vessels (micro- and macro- vasculature), blood flow and tissue perfusion before, during
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 415
- current approval status
- not_reconciled
- duplicate text group
- dup-939fc73fc43913aba94c
- extraction review status
- automated_candidate_pending_source_review
- generic names
- INDOCYANINE GREEN
- id
- ind-span-2d1d439f4dc5ebcf225e
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- positive predicate support span
- Source null
- qualifier mentions
- context exact
- • Ophthalmic angiography in adults and pediatric patients ( 1.4 )
- kind
- age
- polarity
- not_inferred
- span
- end
- 649
- end exclusive
- true
- exact text
- adults
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 643
- context exact
- • Ophthalmic angiography in adults and pediatric patients ( 1.4 )
- kind
- age
- polarity
- not_inferred
- span
- end
- 672
- end exclusive
- true
- exact text
- pediatric patients
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 654
- regulatory links
- schema version
- 0.1.0
- source batch sha256
- a9df7a5786dc51557d38f2a0881b5b5e9ae02ae396a6798e39ac96f586bcc5e6
- source defined aliases
- source span
- end
- 680
- end exclusive
- true
- exact text
- • Ophthalmic angiography in adults and pediatric patients ( 1.4 )
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 615
- source url
- https://api.fda.gov/drug/label.json?search=id%3A%22bb82db71-b087-4274-bd9c-cb388d7dbaeb%22
- spl effective date
- 2026-01-30
- spl set id
- ccd92843-1f0a-4ece-9978-4b300d158886
- spl version
- 4
- structured fields status
- not_extracted_no_values_inferred_from_mentions
- structured indication
- age
- Source null
- approval pathway
- Source null
- biomarker and test
- Source null
- disease stage
- Source null
- limitations
- Source null
- line
- Source null
- prior therapy
- Source null
- regimen
- Source null
- tumor histology
- Source null
- use intent
- unclear
Passage 6 · positive indication candidate
- application numbers
- NDA011525
- brand names
- IC-Green
- classification reasons
- explicit_positive_indication_predicate
- diagnostic_use_words
- clinical review status
- pending
- content role
- positive_indication_candidate
- context span
- end
- 1296
- end exclusive
- true
- exact text
- Fluorescence imaging of lymph nodes and lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer ( 1.3 ) • Ophthalmic angiography in adults and pediatric patients ( 1.4 ) 1.1 Visualization of Vessels, Blood Flow and Tissue Perfusion IC-GREEN is indicated for fluorescence imaging of vessels (micro- and macro- vasculature), blood flow and tissue perfusion before, during and after vascular, gastrointestinal, organ transplant, plastic, micro- and reconstructive surgeries, including general minimally invasive surgical procedures in adults and pediatric patients aged 1 month and older. 1.2 Visualization of Extrahepatic Biliary Ducts IC-GREEN is indicated for fluorescence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older . 1.3 Lymphatic M
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 481
- current approval status
- not_reconciled
- duplicate text group
- dup-0afdb0a6536ec04102ec
- extraction review status
- automated_candidate_pending_source_review
- generic names
- INDOCYANINE GREEN
- id
- ind-span-510e52fb329b4196fe55
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- positive predicate support span
- end
- 764
- end exclusive
- true
- exact text
- is indicated
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 752
- qualifier mentions
- context exact
- including general minimally invasive surgical procedures in adults and pediatric patients aged 1 month and older.
- kind
- age
- polarity
- not_inferred
- span
- end
- 1049
- end exclusive
- true
- exact text
- adults
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1043
- context exact
- eneral minimally invasive surgical procedures in adults and pediatric patients aged 1 month and older.
- kind
- age
- polarity
- not_inferred
- span
- end
- 1072
- end exclusive
- true
- exact text
- pediatric patients
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1054
- context exact
- vasive surgical procedures in adults and pediatric patients aged 1 month and older.
- kind
- age
- polarity
- not_inferred
- span
- end
- 1095
- end exclusive
- true
- exact text
- aged 1 month and older
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1073
- regulatory links
- schema version
- 0.1.0
- source batch sha256
- a9df7a5786dc51557d38f2a0881b5b5e9ae02ae396a6798e39ac96f586bcc5e6
- source defined aliases
- source span
- end
- 1096
- end exclusive
- true
- exact text
- 1.1 Visualization of Vessels, Blood Flow and Tissue Perfusion IC-GREEN is indicated for fluorescence imaging of vessels (micro- and macro- vasculature), blood flow and tissue perfusion before, during and after vascular, gastrointestinal, organ transplant, plastic, micro- and reconstructive surgeries, including general minimally invasive surgical procedures in adults and pediatric patients aged 1 month and older.
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 681
- source url
- https://api.fda.gov/drug/label.json?search=id%3A%22bb82db71-b087-4274-bd9c-cb388d7dbaeb%22
- spl effective date
- 2026-01-30
- spl set id
- ccd92843-1f0a-4ece-9978-4b300d158886
- spl version
- 4
- structured fields status
- not_extracted_no_values_inferred_from_mentions
- structured indication
- age
- Source null
- approval pathway
- Source null
- biomarker and test
- Source null
- disease stage
- Source null
- limitations
- Source null
- line
- Source null
- prior therapy
- Source null
- regimen
- Source null
- tumor histology
- Source null
- use intent
- diagnostic_candidate
Passage 7 · positive indication candidate
- application numbers
- NDA011525
- brand names
- IC-Green
- classification reasons
- explicit_positive_indication_predicate
- diagnostic_use_words
- clinical review status
- pending
- content role
- positive_indication_candidate
- context span
- end
- 1480
- end exclusive
- true
- exact text
- ar, gastrointestinal, organ transplant, plastic, micro- and reconstructive surgeries, including general minimally invasive surgical procedures in adults and pediatric patients aged 1 month and older. 1.2 Visualization of Extrahepatic Biliary Ducts IC-GREEN is indicated for fluorescence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older . 1.3 Lymphatic Mapping of Cervical and Uterine Cancer IC-GREEN is indicated for fluorescence imaging of lymph nodes and delineation of lymphatic vessels during lymphatic mapping in adults with cervica
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 897
- current approval status
- not_reconciled
- duplicate text group
- dup-deae1f17222a17638826
- extraction review status
- automated_candidate_pending_source_review
- generic names
- INDOCYANINE GREEN
- id
- ind-span-2df4cec771e336592f75
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- positive predicate support span
- end
- 1166
- end exclusive
- true
- exact text
- is indicated
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1154
- qualifier mentions
- context exact
- d for fluorescence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older .
- kind
- age
- polarity
- not_inferred
- span
- end
- 1231
- end exclusive
- true
- exact text
- adults
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1225
- context exact
- escence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older .
- kind
- age
- polarity
- not_inferred
- span
- end
- 1254
- end exclusive
- true
- exact text
- pediatric patients
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1236
- context exact
- extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older .
- kind
- age
- polarity
- not_inferred
- span
- end
- 1278
- end exclusive
- true
- exact text
- aged 12 years and older
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1255
- regulatory links
- schema version
- 0.1.0
- source batch sha256
- a9df7a5786dc51557d38f2a0881b5b5e9ae02ae396a6798e39ac96f586bcc5e6
- source defined aliases
- source span
- end
- 1280
- end exclusive
- true
- exact text
- 1.2 Visualization of Extrahepatic Biliary Ducts IC-GREEN is indicated for fluorescence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older .
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1097
- source url
- https://api.fda.gov/drug/label.json?search=id%3A%22bb82db71-b087-4274-bd9c-cb388d7dbaeb%22
- spl effective date
- 2026-01-30
- spl set id
- ccd92843-1f0a-4ece-9978-4b300d158886
- spl version
- 4
- structured fields status
- not_extracted_no_values_inferred_from_mentions
- structured indication
- age
- Source null
- approval pathway
- Source null
- biomarker and test
- Source null
- disease stage
- Source null
- limitations
- Source null
- line
- Source null
- prior therapy
- Source null
- regimen
- Source null
- tumor histology
- Source null
- use intent
- diagnostic_candidate
Passage 8 · positive indication candidate
- application numbers
- NDA011525
- brand names
- IC-Green
- classification reasons
- explicit_positive_indication_predicate
- diagnostic_use_words
- clinical review status
- pending
- content role
- positive_indication_candidate
- context span
- end
- 1688
- end exclusive
- true
- exact text
- onth and older. 1.2 Visualization of Extrahepatic Biliary Ducts IC-GREEN is indicated for fluorescence imaging of extrahepatic biliary ducts in adults and pediatric patients aged 12 years and older . 1.3 Lymphatic Mapping of Cervical and Uterine Cancer IC-GREEN is indicated for fluorescence imaging of lymph nodes and delineation of lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer for which this procedure is a component of intraoperative management . 1.4 Ophthalmic Angiography IC-GREEN is indicated for use in ophthalmic angiography in adults and pediatric patients.
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1081
- current approval status
- not_reconciled
- duplicate text group
- dup-e32d902b38e9c4126f24
- extraction review status
- automated_candidate_pending_source_review
- generic names
- INDOCYANINE GREEN
- id
- ind-span-e8f6f4f3add76b8ad746
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- positive predicate support span
- end
- 1355
- end exclusive
- true
- exact text
- is indicated
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1343
- qualifier mentions
- context exact
- elineation of lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer for which this procedure i
- kind
- age
- polarity
- not_inferred
- span
- end
- 1467
- end exclusive
- true
- exact text
- adults
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1461
- regulatory links
- schema version
- 0.1.0
- source batch sha256
- a9df7a5786dc51557d38f2a0881b5b5e9ae02ae396a6798e39ac96f586bcc5e6
- source defined aliases
- source span
- end
- 1571
- end exclusive
- true
- exact text
- 1.3 Lymphatic Mapping of Cervical and Uterine Cancer IC-GREEN is indicated for fluorescence imaging of lymph nodes and delineation of lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer for which this procedure is a component of intraoperative management .
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1281
- source url
- https://api.fda.gov/drug/label.json?search=id%3A%22bb82db71-b087-4274-bd9c-cb388d7dbaeb%22
- spl effective date
- 2026-01-30
- spl set id
- ccd92843-1f0a-4ece-9978-4b300d158886
- spl version
- 4
- structured fields status
- not_extracted_no_values_inferred_from_mentions
- structured indication
- age
- Source null
- approval pathway
- Source null
- biomarker and test
- Source null
- disease stage
- Source null
- limitations
- Source null
- line
- Source null
- prior therapy
- Source null
- regimen
- Source null
- tumor histology
- Source null
- use intent
- diagnostic_candidate
Passage 9 · positive indication candidate
- application numbers
- NDA011525
- brand names
- IC-Green
- classification reasons
- explicit_positive_indication_predicate
- no_tumor_directed_keyword_in_positive_statement
- clinical review status
- pending
- content role
- positive_indication_candidate
- context span
- end
- 1688
- end exclusive
- true
- exact text
- imaging of lymph nodes and delineation of lymphatic vessels during lymphatic mapping in adults with cervical and uterine cancer for which this procedure is a component of intraoperative management . 1.4 Ophthalmic Angiography IC-GREEN is indicated for use in ophthalmic angiography in adults and pediatric patients.
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1372
- current approval status
- not_reconciled
- duplicate text group
- dup-4f77d17529b6057071cb
- extraction review status
- automated_candidate_pending_source_review
- generic names
- INDOCYANINE GREEN
- id
- ind-span-a00a14ada538acc0ce7b
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- positive predicate support span
- end
- 1620
- end exclusive
- true
- exact text
- is indicated
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1608
- qualifier mentions
- context exact
- IC-GREEN is indicated for use in ophthalmic angiography in adults and pediatric patients.
- kind
- age
- polarity
- not_inferred
- span
- end
- 1664
- end exclusive
- true
- exact text
- adults
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1658
- context exact
- s indicated for use in ophthalmic angiography in adults and pediatric patients.
- kind
- age
- polarity
- not_inferred
- span
- end
- 1687
- end exclusive
- true
- exact text
- pediatric patients
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1669
- regulatory links
- schema version
- 0.1.0
- source batch sha256
- a9df7a5786dc51557d38f2a0881b5b5e9ae02ae396a6798e39ac96f586bcc5e6
- source defined aliases
- source span
- end
- 1688
- end exclusive
- true
- exact text
- 1.4 Ophthalmic Angiography IC-GREEN is indicated for use in ophthalmic angiography in adults and pediatric patients.
- label id
- bb82db71-b087-4274-bd9c-cb388d7dbaeb
- offset unit
- unicode_code_points
- source array index
- 0
- source field
- indications_and_usage_exact
- source text sha256
- b87f73627c1de95da9ef980034d34d2ff5ad4134d706f2135909d88a39d1577e
- start
- 1572
- source url
- https://api.fda.gov/drug/label.json?search=id%3A%22bb82db71-b087-4274-bd9c-cb388d7dbaeb%22
- spl effective date
- 2026-01-30
- spl set id
- ccd92843-1f0a-4ece-9978-4b300d158886
- spl version
- 4
- structured fields status
- not_extracted_no_values_inferred_from_mentions
- structured indication
- age
- Source null
- approval pathway
- Source null
- biomarker and test
- Source null
- disease stage
- Source null
- limitations
- Source null
- line
- Source null
- prior therapy
- Source null
- regimen
- Source null
- tumor histology
- Source null
- use intent
- non_oncology_or_unclear_candidate
Preserved source evidence · Not medical advice
Triangle